{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T10:46:44Z","timestamp":1791802004727,"version":"4.3.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are chronic, relapsing inflammatory diseases, yet reliable biomarkers for detecting relapse and organ involvement remain limited. This study aimed to identify plasma protein biomarkers that distinguish active disease from remission and to explore markers associated with lung and kidney involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Plasma samples from 113 patients with granulomatosis with polyangiitis or microscopic polyangiitis (68 active disease and 45 remission) were profiled using a proximity extension assay targeting 181 inflammation- and cardiovascular-related proteins. Clinical data, including CRP and Birmingham vasculitis activity score (BVAS), were collected at sampling. Differential protein expression was assessed using ANOVA, with top candidates validated in independent sample cohorts (plasma samples,\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a074; serum samples,\n                      <jats:italic>n<\/jats:italic>\n                      = 34). Correlations with BVAS and CRP and discriminatory performance (AUC) were evaluated. Associations with chest- and kidney-specific BVAS were also examined.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 57 proteins were differentially expressed between active disease and remission. Seven proteins (ST2, OPN, IL-2RA, CCL23, IL-6, Flt3L, and SCF) were validated in independent cohorts and showed strong associations with disease activity. Several demonstrated high discriminatory ability (AUC \u2265 0.80) between active disease and remission. Multiple proteins correlated with organ-specific BVAS scores: seven for chest involvement and 16 for kidney involvement, after adjustment for kidney function-related protein variation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identifies a robust panel of plasma proteins that differentiate active AAV from remission and correlate with global and organ-specific disease activity. These biomarkers may enhance non-invasive disease monitoring and support earlier recognition of relapse and organ involvement in AAV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1848693","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:40:31Z","timestamp":1780638031000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Large-scale proteome profiling identifies circulating biomarkers for disease activity and organ involvement in ANCA-associated vasculitides"],"prefix":"10.3389","volume":"17","author":[{"given":"Erik","family":"Hellbacher","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, Uppsala University","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Knight","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Uppsala University","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hemmingsson","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Juto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, Karolinska Institutet","place":["Stockholm, Sweden"]},{"name":"Unit of Rheumatology, Karolinska University Hospital","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, Karolinska Institutet","place":["Stockholm, Sweden"]},{"name":"Unit of Rheumatology, Karolinska University Hospital","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Bruchfeld","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Karolinska University Hospital and CLINTEC Karolinska Institutet","place":["Stockholm, Sweden"]},{"name":"Department of Nephrology, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]},{"name":"Department of Health, Medicine and Caring Sciences, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Weiner","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]},{"name":"Department of Health, Medicine and Caring Sciences, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]},{"name":"Department of Clinical Nephrology, Region \u00d6sterg\u00f6tland","place":["Link\u00f6ping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"S\u00f6derbergh","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, \u00d6rebro University Hospital","place":["\u00d6rebro, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Ohlsson","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Division of Clinical Sciences, Lund University and Sk\u00e5ne University Hospital","place":["Lund, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rille","family":"Pullerits","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg","place":["Gothenburg, Sweden"]},{"name":"Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital","place":["Gothenburg, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sj\u00f6wall","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solbritt","family":"Rantap\u00e4\u00e4-Dahlqvist","sequence":"additional","affiliation":[{"name":"Department of Public Health and Clinical Medicine, Ume\u00e5 University","place":["Ume\u00e5, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Dahlqvist","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Uppsala University","place":["Uppsala, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224623","article-title":"Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials","volume":"83","author":"Delestre","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roaf052","article-title":"Nation-wide cohort study of Japanese patients with ANCA-associated vasculitis using rituximab: effectiveness and safety after two years","volume":"35","author":"Nagasaka","year":"2025","journal-title":"Mod Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"Pagnoux","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.70009","article-title":"In-depth analysis of disease manifestations in antineutrophil cytoplasmic antibody-associated vasculitides identifies distinct clinical phenotypes","volume":"7","author":"Lindberg","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa541","article-title":"Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models","volume":"60","author":"McClure","year":"2021","journal-title":"Rheumatol (Oxford)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.36141\/svdld.v40i2.13243","article-title":"The factors predicting development of serious infections in ANCA-associated vasculitis","volume":"40","author":"Uslu Yurteri","year":"2023","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac320","article-title":"Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis","volume":"38","author":"Sanchez Alamo","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the birmingham vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xagr.2023.100244","article-title":"Comparative predictive power of serum vs plasma proteomic signatures in feto-maternal medicine","volume":"3","author":"Espinosa","year":"2023","journal-title":"AJOG Glob Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015050511","article-title":"Urinary soluble CD163 in active renal vasculitis","volume":"27","author":"O'Reilly","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.39814","article-title":"Association of serum calprotectin (S100A8\/A9) level with disease relapse in proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis","volume":"69","author":"Pepper","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.146456","article-title":"Correlation of serum level of high mobility group box 1 with the burden of granulomatous inflammation in granulomatosis with polyangiitis (Wegener\u2019s)","volume":"70","author":"Henes","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/03009742.2022.2045790","article-title":"Pentraxin-3 - a potential biomarker in ANCA-associated vasculitis","volume":"52","author":"Jonasdottir","year":"2023","journal-title":"Scand J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/603750","article-title":"Increased levels of soluble ST2 in patients with active newly diagnosed ANCA-associated vasculitis","volume":"2015","author":"Hladinova","year":"2015","journal-title":"Mediators Inflammation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13075-025-03552-5","article-title":"CCL23 is a potential biomarker for antineutrophil cytoplasmic antibody-associated vasculitis","volume":"27","author":"Hao","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00176","article-title":"Human neutrophils produce CCL23 in response to various TLR-agonists and TNFalpha","volume":"7","author":"Arruda-Silva","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1600754","article-title":"The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis","volume":"16","author":"Hellbacher","year":"2025","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3899\/jrheum.180713","article-title":"Osteopontin and disease activity in patients with recent-onset systemic lupus erythematosus: results from the SLICC inception cohort","volume":"46","author":"Wirestam","year":"2019","journal-title":"J Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(88)90005-4","article-title":"Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity","volume":"1","author":"Wood","year":"1988","journal-title":"J Autoimmun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s1359-6101(02)00027-8","article-title":"IL-6 in autoimmune disease and chronic inflammatory proliferative disease","volume":"13","author":"Ishihara","year":"2002","journal-title":"Cytokine Growth Fact Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000547044","article-title":"Serum NF-kappaB-regulated biomarkers of proliferative lupus nephritis","volume":"5","author":"Shoctor","year":"2025","journal-title":"Glomerular Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature15521","article-title":"BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis","volume":"527","author":"Canver","year":"2015","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2015.01121","article-title":"Serum concentrations of Flt-3 ligand in rheumatic diseases","volume":"9","author":"Nakamura","year":"2015","journal-title":"Biosci Trends"},{"key":"B27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1089\/thy.1998.8.499","article-title":"An elevation of stem cell factor in patients with hyperthyroid Graves\u2019 disease","volume":"8","author":"Yamada","year":"1998","journal-title":"Thyroid"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201981","article-title":"Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis","volume":"72","author":"Monach","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000000000000009","article-title":"Serum biomarkers of disease activity in longitudinal assessment of patients with ANCA-associated vasculitis","volume":"4","author":"Monach","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13075-017-1429-3","article-title":"Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"19","author":"Ishizaki","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfad009","article-title":"Challenges of defining renal response in ANCA-associated vasculitis: call to action","volume":"16","author":"Odler","year":"2023","journal-title":"Clin Kidney J"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2022.27","article-title":"The emerging role of NOTCH3 receptor signalling in human lung diseases","volume":"24","author":"Bodas","year":"2022","journal-title":"Expert Rev Mol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1576849","article-title":"Defining a non-eosinophilic inflammatory subtype in COPD: the role of CXCL9 and type 1 immune responses","volume":"16","author":"Chengsheng","year":"2025","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"39204","DOI":"10.1038\/s41598-025-14278-4","article-title":"Neutrophil-derived Il1r2 modulates inflammation and alleviates acute lung injury by promoting M2 macrophage polarization","volume":"15","author":"Ding","year":"2025","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.02.046","article-title":"Dlk1-mediated temporal regulation of Notch signaling is required for differentiation of alveolar type II to type I cells during repair","volume":"26","author":"Finn","year":"2019","journal-title":"Cell Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.120.016463","article-title":"Impact of kidney function on the blood proteome and on protein cardiovascular risk biomarkers in patients with stable coronary heart disease","volume":"9","author":"Yang","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1589130","article-title":"Neutralizing the Th1 effector cytokines, IFN-gamma and TNF-alpha, attenuates established experimental autoimmune anti-myeloperoxidase glomerulonephritis","volume":"16","author":"Nagai","year":"2025","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00077.x","article-title":"IL-18 translational inhibition restricts IFN-gamma expression in crescentic glomerulonephritis","volume":"64","author":"Garcia","year":"2003","journal-title":"Kidney Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00683.2011","article-title":"Renal IL-17 expression in human ANCA-associated glomerulonephritis","volume":"302","author":"Velden","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1602025","article-title":"Pathogenic role for gammadelta T cells in autoimmune anti-myeloperoxidase glomerulonephritis","volume":"199","author":"Gan","year":"2017","journal-title":"J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1848693\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T10:07:38Z","timestamp":1791799658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1848693\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2026.1848693"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1848693","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"article-number":"1848693"}}